A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes. Widely prescribed and wildly popular, particularly for the unprecedented ...

The analysis used data from more than two million diabetes patients in the United States, including about 216,000 taking the popular drugs, to map out their ... diagnosed for obesity or type ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of ...

Researchers in Zurich have mapped cellular changes in overweight individuals, which could shed light on the link between obesity and certain metabol ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

the research showed that use of the new diabetes and obesity drugs reduced the risk by 12%, but Al-Aly said the figure is likely larger because the study spans just 3.5 years and Alzheimer’s ...